Dusty Tenney - May 3, 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: COO and President
Signature: /s/ Dusty Tenney
Stock symbol: BLFS
Transactions as of: May 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/13/2021, 08:00 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock	Award		+32.1K			32.1K	May 3, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BLFS	Restricted Stock Award	Award	$0	+6.42K		$0.00	6.42K	May 3, 2021	Common Stock	6.42K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock granted pursuant to the Biolife Solutions 2013 Performance Incentive Plan (the "Plan"), as amended, of Biolife Solutions, Inc. (the "Company") on July 17, 2020 and vests 25% on the first anniversary of the grant date and thereafter yearly, in 4 equal annual installments. The restricted stock was granted to the reporting person as part of the reporting person's compensation for service to the Company.
F2	The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

Content

Restricted stock granted pursuant to the Biolife Solutions 2013 Performance Incentive Plan (the "Plan"), as amended, of Biolife Solutions, Inc. (the "Company") on July 17, 2020 and vests 25% on the first anniversary of the grant date and thereafter yearly, in 4 equal annual installments. The restricted stock was granted to the reporting person as part of the reporting person's compensation for service to the Company.

The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.